Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,894Revenue $M2,220Net Margin (%)20.8Altman Z-Score9.0
Enterprise Value $M20,565EPS $3.1Operating Margin %27.6Piotroski F-Score8
P/E(ttm)41.6Beneish M-Score-2.1Pre-tax Margin (%)26.3Higher ROA y-yY
Price/Book11.310-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales9.95-y EBITDA Growth Rate %21.7Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow55.1y-y EBITDA Growth Rate %50.3ROA % (ttm)12.9Higher Current Ratio y-yY
Dividend Yield %--PEG1.9ROE % (ttm)26.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M146ROIC % (ttm)31.2Gross Margin Increase y-yY

Gurus Latest Trades with ILMN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ILMNVanguard Health Care Fund 2015-12-31 Reduce-0.09%$140.17 - $194.18
($166.62)
$ 142.72-14%Reduce -7.86%2,787,466
ILMNSteve Mandel 2015-09-30 Reduce-1.69%$167.51 - $240.02
($208.03)
$ 142.72-31%Reduce -36.43%3,609,735
ILMNJulian Robertson 2015-09-30 Add0.91%$167.51 - $240.02
($208.03)
$ 142.72-31%Add 32.19%158,500
ILMNVanguard Health Care Fund 2015-09-30 Add0.24%$167.51 - $240.02
($208.03)
$ 142.72-31%Add 26.02%3,025,105
ILMNRon Baron 2015-09-30 Reduce-0.04%$167.51 - $240.02
($208.03)
$ 142.72-31%Reduce -3.35%1,458,569
ILMNSteve Mandel 2015-06-30 Add2.28%$182.21 - $220.75
($200.55)
$ 142.72-29%Add 96.48%5,678,537
ILMNJulian Robertson 2015-06-30 Add0.52%$182.21 - $220.75
($200.55)
$ 142.72-29%Add 16.41%119,900
ILMNRon Baron 2015-06-30 Add0.25%$182.21 - $220.75
($200.55)
$ 142.72-29%Add 23.70%1,509,065
ILMNVanguard Health Care Fund 2015-06-30 Add0.2%$182.21 - $220.75
($200.55)
$ 142.72-29%Add 24.20%2,400,500
ILMNJoel Greenblatt 2015-06-30 Sold Out -0.02%$182.21 - $220.75
($200.55)
$ 142.72-29%Sold Out0
ILMNSteve Mandel 2015-03-31 Buy 2.03%$180.91 - $203.25
($193.62)
$ 142.72-26%New holding2,890,103
ILMNRon Baron 2015-03-31 Reduce-0.13%$180.91 - $203.25
($193.62)
$ 142.72-26%Reduce -13.37%1,219,938
ILMNJoel Greenblatt 2015-03-31 Add0.01%$180.91 - $203.25
($193.62)
$ 142.72-26%Add 79.87%13,069
ILMNMario Gabelli 2015-03-31 Sold Out -0.0013%$180.91 - $203.25
($193.62)
$ 142.72-26%Sold Out0
ILMNJulian Robertson 2014-12-31 Buy 3.7%$149.12 - $194.33
($181.71)
$ 142.72-21%New holding103,000
ILMNGeorge Soros 2014-12-31 Sold Out -0.09%$149.12 - $194.33
($181.71)
$ 142.72-21%Sold Out0
ILMNJoel Greenblatt 2014-12-31 Reduce-0.01%$149.12 - $194.33
($181.71)
$ 142.72-21%Reduce -44.01%7,266
ILMNMario Gabelli 2014-12-31 Reduce$149.12 - $194.33
($181.47)
$ 142.72-21%Reduce -65.85%1,400
ILMNGeorge Soros 2014-09-30 Reduce-0.16%$159.18 - $182.86
($171.81)
$ 142.72-17%Reduce -61.51%75,102
ILMNVanguard Health Care Fund 2014-09-30 Reduce-0.11%$159.18 - $182.86
($171.81)
$ 142.72-17%Reduce -10.54%1,932,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ILMN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ILMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OSTADAN OMEADEVP Ops, Products, Strategy 2016-02-01Sell1,108$156.73-8.94view
FLATLEY JAY TCEO 2016-01-26Sell20,000$171.7-16.88view
FLATLEY JAY TCEO 2016-01-13Sell20,000$168.81-15.46view
BRADBURY DANIELDirector 2016-01-04Sell1,700$182.8-21.93view
Dadswell CharlesSr VP & General Counsel 2015-12-28Sell168$188.63-24.34view
FLATLEY JAY TCEO 2015-12-22Sell25,000$185.38-23.01view
WHITFIELD ROY ADirector 2015-12-14Sell3,750$175.07-18.48view
Bianchi Paul LSr. VP, Human Resources 2015-12-11Sell197$179.9-20.67view
OSTADAN OMEADEVP Ops, Products, Strategy 2015-12-11Sell260$179.9-20.67view
BRADBURY DANIELDirector 2015-12-10Sell1,700$182.37-21.74view

Press Releases about ILMN :

Quarterly/Annual Reports about ILMN:

News about ILMN:

Articles On GuruFocus.com
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Julian Robertson Keeps Buying Citigroup, Netflix, Facebook Dec 07 2015 
Halvorsen's Investment Makes Broadcom His Fifth-Most Valuable Stake Dec 05 2015 
Barron Asset Fund Third Quarter Letter - Part One Nov 02 2015 
Baron Funds Comments on Illumina Inc. Nov 02 2015 
Halvorsen Buys Amazon, Sells Out Micron Technology During Q2 Oct 05 2015 
Ron Baron's Largest Purchases During Second Quarter Sep 28 2015 
Frank Sands Shows Bold Side in Second-Quarter Trades Sep 13 2015 
Perigon Wealth Management's Largest Buys in Second Quarter Sep 08 2015 
Meridian Funds Comments on Illumina Aug 31 2015 

More From Other Websites
Meet the Google executive tapped to run the cancer-screening startup backed by Bill Gates and Jeff... Feb 11 2016
Genomics England Enters Bioinformatics Partnership with Illumina Feb 11 2016
Genomics England Enters Bioinformatics Partnership with Illumina Feb 11 2016
ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2016
Cancer Took His Wife. Now He's CEO Of One Of The Most Audacious Cancer Startups In Years Feb 10 2016
Google's Huber to Lead Illumina Cancer-Detecting Startup Grail Feb 10 2016
Illumina Building Long Read Application Partnerships Feb 10 2016
Former Google executive to lead cancer diagnostics firm Feb 10 2016
Former Google executive to lead cancer diagnostics firm Feb 10 2016
Former Google executive to lead cancer diagnostics firm Feb 10 2016
STZ carries Matrix Capital in January. WDAY & DATA drag Feb 09 2016
Illumina, Inc. Earnings Analysis: 2015 By the Numbers Feb 04 2016
Illumina downgraded by Canaccord Genuity Feb 04 2016
Top Analyst Upgrades and Downgrades: GoPro, Illumina, Mattel, Match, Peabody, Petrobras, Wayfair,... Feb 04 2016
Analysts' Actions -- GoPro, Boston Beer, Match, Whirlpool and More Feb 04 2016
Stock Indexes Trade Mixed, But Medicals Fall; Illumina Hits Low Feb 03 2016
Illumina's Earnings Miss, Revenues Beat; MiSeq Orders High Feb 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK